Should You Buy CrowdStrike After Its Recent Stock Split? The Answer Might Surprise You.

CrowStrike executed a 4-for-1 stock split, cutting the share price from $767 to $194, but reiterates that the split doesn’t change underlying value. The company reported $5.5B total ARR (+24% YoY) with Falcon Flex ARR doubling to $1.9B, and raised full-year ARR guidance by $50M to $6.54B (midpoint). Despite strong fundamentals, the stock trades at an elevated 38.7x P/S—near its highest since 2019—suggesting near-term upside may be limited without a long-term valuation reset.

Analysis

The split is a liquidity event, not a thesis event. Any near-term support from lower per-share price or retail accessibility is likely to show up first in options activity and momentum ownership, not in incremental enterprise demand; that means the main effect is a 1-4 week technical bid, not a durable rerating. The bigger issue is that the market is already pricing near-flawless execution, so even strong quarters can fail to expand the multiple if guidance does not re-accelerate.

On competitive dynamics, CRWD’s premium creates a valuation umbrella for PANW and ZS. If buyers want cybersecurity exposure but balk at paying a top-of-cycle multiple, capital can rotate to the cheaper incumbents with similar platform narratives, especially if budget holders continue consolidating vendors rather than expanding spend. The second-order loser is the long tail of point-solution vendors: platform winners can still take share, but that doesn’t automatically translate into upside for the highest-multiple winner when the category itself is mature.

The real catalyst path is the next earnings cycle: billings quality, module attach, and net retention will matter more than the split. If ARR growth cools even modestly, the downside could come fast because duration is embedded in the stock. Conversely, if AI-security monetization proves real and not just a feature story, the multiple can stay elevated longer than skeptics expect; the key falsifier is continued >20% growth with expanding free-cash-flow margins over the next 2-3 quarters.

Key Decisions for Investors

• Prefer a relative-value short CRWD vs long PANW basket over outright shorting CRWD; use any post-split strength to initiate into the next 1-3 month earnings window. Risk/reward improves if CRWD holds a persistent premium to peers without commensurate acceleration in billings.
• If you need long cybersecurity exposure, rotate to ZS or PANW rather than chase CRWD at peak-multiple levels; this captures the same category tailwind with less valuation compression risk over the next 1-3 months.
• Do not buy the split as a standalone catalyst; wait for a pullback or post-earnings setup. The trade only becomes attractive if CRWD guidance stops improving while the stock remains priced for perfection.
• Alert item: if the next quarter shows billings/ARR deceleration or weaker module expansion, consider put spreads on CRWD for a defined-risk short; the thesis is invalidated if growth and margin expansion both reaccelerate.